Fecal incontinence patients with low severity scores but poor quality of life should not be excluded from biofeedback therapy, according to an Australian study.
In an analysis of 363 women with fecal incontinence, approximately two-thirds had a response to biofeedback treatment, reported Yoav Mazor, MD, of the Royal North Shore Hospital and the University of Sydney in New South Wales, and colleagues. Urge fecal incontinence was the only baseline variable associated with a positive response, while baseline severity of symptoms and quality-of-life measures were associated with greater improvement in this variable but not overall response.